Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SERPINB11 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | SLC35E2B | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | PAF1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | ZNF496 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | SAMD1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
mRNA | MRPL34 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | NOA1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | ANKRD34A | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | LYST | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
mRNA | GAGE12J | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |